Durable treatment of ameloblastoma with single agent BRAFi Re: Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma
J Natl Cancer Inst
.
2016 Sep 26;109(1):djw190.
doi: 10.1093/jnci/djw190.
Print 2017 Jan.
Authors
Daniel L Faden
1
,
Alain Algazi
2
Affiliations
1
Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, California, San Francisco, CA, USA.
2
Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, California, San Francisco, CA, USA.
PMID:
27671684
DOI:
10.1093/jnci/djw190
No abstract available
Publication types
Letter